RSI-MRI+ is an AI-enabled medical device from MultiModal Imaging Services Corporation (dba HealthLytix), listed by FDA (510(k), K191278) with a decision date of 2019-11-19. Review panel: Radiology.
| FDA submission number | K191278 |
|---|---|
| Pathway | 510(k) |
| Company | MultiModal Imaging Services Corporation (dba HealthLytix) |
| Review panel (specialty) | Radiology |
| FDA decision date | 2019-11-19 |
| Decision | Substantially Equivalent |
| Product code | LLZ |
| Classification | System, Image Processing, Radiological |
| Device class | 2 |
| Regulation number | 892.2050 |
| Review time (calendar days) | 190 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.